The store will not work correctly when cookies are disabled.
[5-(3,5-dimethylbenzo[d]isoxazol-6-yl)(2-thienyl)]-N-(2-fluorophenyl)carboxamide
ID: ALA3731651
Chembl Id: CHEMBL3731651
PubChem CID: 68062149
Max Phase: Preclinical
Molecular Formula: C20H15FN2O2S
Molecular Weight: 366.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2c(C)noc2cc1-c1ccc(C(=O)Nc2ccccc2F)s1
Standard InChI: InChI=1S/C20H15FN2O2S/c1-11-9-14-12(2)23-25-17(14)10-13(11)18-7-8-19(26-18)20(24)22-16-6-4-3-5-15(16)21/h3-10H,1-2H3,(H,22,24)
Standard InChI Key: GEWKCEAVMAIXAJ-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.42 | Molecular Weight (Monoisotopic): 366.0838 | AlogP: 5.56 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.60 | CX Basic pKa: 0.34 | CX LogP: 4.79 | CX LogD: 4.79 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.52 | Np Likeness Score: -1.77 |
References
1. (2012) Compounds that modulate intracellular calcium, |